α-Glucosidase-IN-11

Modify Date: 2025-10-20 00:41:44

α-Glucosidase-IN-11 Structure
α-Glucosidase-IN-11 structure
Common Name α-Glucosidase-IN-11
CAS Number 2411744-76-6 Molecular Weight 420.41
Density N/A Boiling Point N/A
Molecular Formula C23H20N2O6 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of α-Glucosidase-IN-11


α-Glucosidase-IN-11 is a highly permeable competitive α-glucosidase inhibitor with the IC50 value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels[1].

 Names

Name α-Glucosidase-IN-11

 α-Glucosidase-IN-11 Biological Activity

Description α-Glucosidase-IN-11 is a highly permeable competitive α-glucosidase inhibitor with the IC50 value of 0.56 μM. α-Glucosidase-IN-11 binds to Trp residues in α-glucosidase and regulates protein folding. α-Glucosidase-IN-11 can be used to regulate blood glucose levels[1].
Related Catalog
In Vitro α-Glucosidase-IN-11 (compound 3k) inhibits α-glucosidase, α-fucosidase and α-mannosidase with the IC50 value of 0.56 μM, 30.4 μM and 41.2 μM, respectively[1]. α-Glucosidase-IN-11 (compound 3k) ( 0.1-100 μM, 24 hours) can induce β-cell proliferation at lower concentration[1]. Cell Proliferation Assay[1] Cell Line: BRIN-BD11 cells (rat beta cell line) Concentration: 0.1-100 μM Incubation Time: 24 hours Result: Showed cell proliferation at low concentration of 1 μM and minor cytotoxic effect at higher concentration greater than 10 μM.
In Vivo α-Glucosidase-IN-11 (compound 3k) (gastric gavage, 60 mg/kg, everyday, 4 weeks) can improve blood glucose levels during fasting[1]. Animal Model: Male Sprague Dawley rats (250e320g)[1] Dosage: 60 mg/kg Administration: Gastric gavage; everyday; 4 weeks Result: Caused a significant drop in fasting blood glucose during the first and second weeks but did not cause a decrease in non-fasting blood glucose for up to four weeks.
References

[1]. Tania Luthra, et al. Discovery of novel pyrido-pyrrolidine hybrid compounds as alpha-glucosidase inhibitors and alternative agent for control of type 1 diabetes. Eur J Med Chem. 2020 Feb 15;188:112034.

 Chemical & Physical Properties

Molecular Formula C23H20N2O6
Molecular Weight 420.41
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.